Ideas

MBTN SW – Update – Decent J-Curve potential

*Looking to add towards the end of the rights issue subscription period that ends on the 9th November *Terms are 7 for 20 at CHF 0.267 raising CHF 250m – trading period 1st November to 7th November, subscription period ends 9th November, new shares to trade 11st November *Short interest around 30-35% *We have seen…

For full note click here...

Closing BUY TMV US, +50%

FED priced for 8/9 hikes this year. I think if China is going to be like this for a while which seems likely then no way the FED gets 8/9 away. Closing for +50% profit and I would be happy to initiate the inverse position and be long bonds/short rates. Bond move gone too far?…

For full note click here...

Monaco Alpha Update: Below is a brief update on each of our names

Below is a brief update on each of our names CCJ         B             +127%    HOLD Performed very well, we continue to like the name and see a lot of prospects for the sector, especially as governments have felt the pressure of from the spike in oil due to the geopolitical tensions. A western Uranium company like…

For full note click here...

BUY CNE LN – India Update – Reiterate Buy

Statement from company overnight saying the company has now concluded all necessary steps required for receiving refund, upon acceptance India will pay USD 1.06bn – working with government to expedite refund – special dividend expected early 2022 We continue to see large upside for the Capricorn (recently changed name from Cairn) Our SOTPs comes in…

For full note click here...

CNE LN – Update – Reiterate BUY, +35% ABS – We continue to see a +50% upside although catalyst probably not until next year

*Announced today that it is working with Indian government to expedite refund *The company has dropped litigation and accepted the governments offer to settle for USD 1bn – inline with what was widely expected *The company reiterates the early 2022 guidance for the special dividend (as previous announced although investors were being more hopeful) *The…

For full note click here...

REPSOL: BOOKING +32% ABS

We initiated a position in February on the back of the potential renewable IPO and our believe that the vaccine roll-out will help boost the oil price as the global economy restarts. Both catalysts have had sizeable impacts on the share price. The IPO still has no specific date so we will book our profits…

For full note click here...